# FVCBankcorp, Inc.: overview FVCB · Nasdaq · CIK 1675644 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/fvcb.md) · [Financials](/companies/fvcb/financials.md) · [Filings](/companies/fvcb/filings.md) · [Insiders](/companies/fvcb/insiders.md) Latest reported revenue: [$549.0k](/filings/0001675644-26-000081.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001675644-26-000081). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [412](/filings/0001675644-25-000146.md) | [379 d](/filings/0001675644-26-000023.md) | [382](/filings/0001675644-26-000059.md) | [392](/filings/0001675644-26-000081.md) | [416](/filings/0001675644-25-000146.md) | [591 d](/filings/0001675644-26-000023.md) | [458](/filings/0001675644-26-000059.md) | [549](/filings/0001675644-26-000081.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [1133.3%](/filings/0001675644-25-000146.md) | [1292.9% d](/filings/0001675644-26-000023.md) | [1352.1%](/filings/0001675644-26-000059.md) | [1445.7%](/filings/0001675644-26-000081.md) | [1341.1%](/filings/0001675644-25-000146.md) | [955.3% d](/filings/0001675644-26-000023.md) | [1394.3%](/filings/0001675644-26-000059.md) | [1497.8%](/filings/0001675644-26-000081.md) | | Diluted EPS | $ per share | [0.25](/filings/0001675644-25-000146.md) | not reported | [0.28](/filings/0001675644-26-000059.md) | [0.31](/filings/0001675644-26-000081.md) | [0.31](/filings/0001675644-25-000146.md) | not reported | [0.35](/filings/0001675644-26-000059.md) | [0.45](/filings/0001675644-26-000081.md) | | Free cash flow | $k | [4,622 d](/filings/0001675644-25-000146.md) | [4,832 d](/filings/0001675644-26-000023.md) | [5,400](/filings/0001675644-26-000059.md) | [3,275 d](/filings/0001675644-26-000081.md) | [7,563 d](/filings/0001675644-25-000146.md) | [7,574 d](/filings/0001675644-26-000023.md) | [7,615](/filings/0001675644-26-000059.md) | [8,917 d](/filings/0001675644-26-000081.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1.6](/filings/0001675644-23-000038.md) | [1.4](/filings/0001675644-24-000036.md) | [1.5](/filings/0001675644-25-000035.md) | [1.6](/filings/0001675644-26-000023.md) | [1.8](/filings/0001675644-26-000023.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [1381.2%](/filings/0001675644-23-000038.md) | [1744.7%](/filings/0001675644-24-000036.md) | [259.3%](/filings/0001675644-25-000035.md) | [963.2%](/filings/0001675644-26-000023.md) | [1238.5%](/filings/0001675644-26-000023.md) | | Diluted EPS | $ per share | [1.20](/filings/0001675644-23-000038.md) | [1.35](/filings/0001675644-24-000036.md) | [0.21](/filings/0001675644-25-000035.md) | [0.82](/filings/0001675644-26-000023.md) | [1.21](/filings/0001675644-26-000023.md) | | Free cash flow | $m | [19.0](/filings/0001675644-23-000038.md) | [22.2](/filings/0001675644-24-000036.md) | [16.1](/filings/0001675644-25-000035.md) | [18.1](/filings/0001675644-26-000023.md) | [23.8](/filings/0001675644-26-000023.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fvcb/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $19.1m | 1,089,368 | | Added +171,129 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $11.7m | 666,910 | | Reduced −27,615 | | [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $10.5m | 693,941 | | Reduced −190,682 | | [Ategra Capital Management, LLC](/funds/1741369.md) | 2026-06-30 | $7.6m | 436,748 | | Unchanged | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $7.3m | 419,731 | | Added +117,564 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $6.7m | 380,377 | | Added +31,920 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $6.6m | 374,567 | | Added +65,896 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $5.7m | 326,525 | | Added +210,050 | | [ENDEAVOUR CAPITAL ADVISORS INC](/funds/1218749.md) | 2026-06-30 | $4.9m | 277,658 | | Reduced −961,475 | | [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $4.1m | 232,886 | | New +232,886 | ## Recent filings [All 583 filings](/companies/fvcb/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-22 | 20:07 ET | [8-K](/filings/0001675644-26-000089.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001675644-26-000089 | | 2026-08-06 | 16:31 ET | [10-Q](/filings/0001675644-26-000081.md) | Quarterly report, period 2026-06-30 | 0001675644-26-000081 | | 2026-07-21 | 20:12 ET | [8-K](/filings/0001675644-26-000077.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001675644-26-000077 | | 2026-05-21 | 15:41 ET | [8-K](/filings/0001675644-26-000064.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001675644-26-000064 | | 2026-05-07 | 18:01 ET | [10-Q](/filings/0001675644-26-000059.md) | Quarterly report, period 2026-03-31 | 0001675644-26-000059 | | 2026-05-05 | 23:30 ET | [8-K](/filings/0001675644-26-000057.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001675644-26-000057 | | 2026-04-21 | 20:27 ET | [8-K](/filings/0001675644-26-000049.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001675644-26-000049 | | 2026-04-07 | 14:27 ET | [DEF 14A](/filings/0001675644-26-000039.md) | Proxy statement, period 2025-12-31 | 0001675644-26-000039 | | 2026-03-25 | 19:18 ET | [10-K/A](/filings/0001675644-26-000023.md) | Annual report, amended, period 2025-12-31 | 0001675644-26-000023 | | 2026-03-20 | 13:58 ET | [8-K](/filings/0001675644-26-000020.md) | 8.01 Other events | 0001675644-26-000020 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001675644-26-000017.md), filed Mar 16, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1675644 - Tickers: FVCB - Exchange: Nasdaq - SIC code: 6022 State Commercial Banks - State of incorporation: VA - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.